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Abstract
Oxazolo[5,4-d]pyrimidines can be considered as 9-oxa-purine analogs of naturally occurring nucleic acid bases. Interest in this ring
system has increased due to recent reports of biologically active derivatives. In particular, 5-aminooxazolo[5,4-d]pyrimidine-7(6H)-
ones  (9-oxa-guanines)  have been shown to  inhibit  ricin.  The preparation of  a  series  of  2-substituted 5-aminooxazolo[5,4-
d]pyrimidin-7(6H)-ones and related 5-thio-oxazolo[5,4-d]pyrimidines is described, including analogs suitable for further elabora-
tion employing “click” chemistry utilizing copper-catalyzed Huisgen 1,3-dipolar cycloadditions. Two of the compounds prepared
were found to inhibit ricin with IC50 ca. 1–3 mM.
Introduction
Oxazolo[5,4-d]pyrimidines  have been reported to  possess  a
variety of biological activities including kinase inhibition [1,2],
adenosine receptor antagonism [3] and tumor growth inhibition
[4]. In particular, 5-aminooxazolo[5,4-d]pyrimidin-7(6H)-ones
[9-oxa-guanines] and related heterocycles have been shown to
inhibit the ability of ricin to inactivate ribosomes [5]. Given
these reports, and the expectation of further applications based
upon similarity to naturally occurring nucleic acid bases, this
heterocyclic ring system continues to generate interest.
Approaches to the oxazolo[5,4-d]pyrimidine ring system gener-
ally involve either cyclodehydration of an 5-(acylamino)-4-
hydroxypyrimidine  [6-10]  or  elaboration  of  a  4-cyano-  or
4-(alkoxycarbonyl)-5-aminooxazole [11-15] (Figure 1), with
only isolated reports of alternative routes [16,17]. However, few
p u b l i c a t i o n s  h a v e  d e s c r i b e d  t h e  p r e p a r a t i o n  o f
5-aminooxazolo[5,4-d]pyrimidin-7(6H)-ones  [5,8,14]  or
5-mercaptooxazolo[5,4-d]pyrimidin-7(6H)-ones [9-oxa-2-thio-
xanthines]  [7,15],  and  in  both  cases,  the  conditions  do  not
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Figure 1: The two general synthetic approaches to oxazolo[5,4-d]pyrimidines.
Figure 2: Thermal cyclodehydration route to 9-oxo-guanine.
appear  to  be  amenable  to  the  preparation  of  oxazolo[5,4-
d]pyrimidines with variations at  the 2-position,  particularly
those  with  additional  functional  groups  or  increased  steric
demand.
In  pursuing  8-methyl-9-oxa-guanine  [2-methyloxazolo[5,4-
d]pyrimidin-7(6H)-one] as an initial lead in the design of inhib-
itors of the ribosome-inactivating protein ricin [5], we set out to
prepare  a  series  of  2-substituted  5-aminooxazolo[5,4-
d]pyrimidin-7(6H)-ones  and  related  5-thio-oxazolo[5,4-
d]pyrimidines. Here we report these studies, which have led to
the preparation of analogs suitable for further elaboration, for
example  by  “click”  chemistry  employing  copper-catalyzed
Huisgen  1,3-dipolar  cycloadditions  [18].
Results and Discussion
Our previous route [5] to 8-methyl-9-oxa-guanine (2a) involved
the thermal cyclodehydration of 5-(acetylamino)-2-amino-4,6-
dihydroxypyrimidine (1a) [19] (Figure 2). Unfortunately, for
other 5-acylamino analogs of 1a, this route failed to afford the
required oxazolo[5,4-d]pyrimidines, presumably due to decom-
position of the product at the temperatures required for cyclode-
hydration. Other cyclodehydration conditions (POCl3,  PPA)
were also unsuccessful.
An alternative route was sought in which the oxazole ring was
formed first, followed by elaboration of the pyrimidine ring.
Our previous work had demonstrated that in the case of ethyl
5-amino-2-methyloxazole-4-carboxylate 3a [20], direct annula-
tion  with  chloroformamidine  in  DMSO  at  120  °C  or  with
2-methylisothiourea sulfate neat or in ethylene glycol at 170 °C
did not afford the oxazolo[5,4-d]pyrimidine 2 (Figure 2). Thus,
a stepwise annulation [15] strategy was explored for the prepar-
ation of analogs of 2 bearing different 2-positions substituents.
The required 5-aminooxazoles 3b,c  were prepared from the
(acylamino)cyanoacetates  5b,c,  which in  turn  were  derived
from ethyl cyanoglyoxylate oxime (4) by reduction followed by
acylation  by  isobutyric  anhydride  or  azidoacetyl  chloride
(Figure 3). Reaction of the aminooxazoles 3b,c with benzoyl-
isothiocyanate afforded the thioureas 6b,c. Direct cyclization of
6b,c  to  oxazolo[5,4-d]pyrimidines  2b,c  by  treatment  with
ammonia in methanol was unsuccessful. However, thioureas
6b,c  were  converted  to  the  desired  2-substituted  the
oxazolo[5,4-d]pyrimidines  2b,c  by  stepwise  methylation
followed by cyclization in the presence of ammonia in meth-
anol. Although the intermediate products after methylation were
not purified,  in the case of 6c  the 1H NMR spectrum of the
crude product following methylation retains the signals for the
ethoxy  group  of  6c  and  displays  a  new  resonance  for  the
S-methyl group at 2.0 ppm (see Supporting Information File 2),
indicating that the intermediate is the S-methylisothiourea A
(Figure 3). The mechanism involved in the conversion of inter-
mediates  such  as  A  to  2  is  not  clear.  It  is  unlikely  that  the
5-(methylthio)oxazolo[5,4-d]pyrimidine  is  an  intermediate
because treatment of 5-(methylthio)oxazolo[5,4-d]pyrimidine
8a (see below) with ammonia in methanol fails to afford 2a.
The thiourea 6b and its analog 6a, which was prepared from
aminooxazole 3a in 51% yield, were also subjected to cycliza-
tion  in  the  presence  of  ethanolic  KOH  to  afford  the
5-mercaptooxazolo[5,4-d]pyrimidin-7(6H)-ones 7a,b (Figure
4). Further elaboration of 7a by alkylation with methyl iodide,
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Figure 3: Preparation of 2-substituted 5-aminooxazolo[5,4-d]pyrimidin-7(6H)-ones.
Figure 4: Preparation of 2-substituted 5-aminooxazolo[5,4-d]pyrimidin-7(6H)-ones and related thioethers.
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Figure 5: Click chemistry elaboration of a 5-(propargylthio)oxazolo[5,4-d]pyrimidine.
benzyl bromide, propargyl bromide, or methyl 6-O-(tolylsulf-
onyl)-α-D-glucopyranoside [21] afforded the thioethers 8a–d,
respectively. The structural assignment of 8a–d as thioethers
rest  principally  on  their  1H  and  13C  NMR  spectra,  which
contain resonances more commensurate with groups attached to
sulfur (e.g., for 8a: 2.2 ppm in 1H and 13 ppm in 13C NMR,
respectively) than to nitrogen, as would be the case for 4- or
3-alkylated 5-mercaptooxazolo[5,4-d]pyrimidine-7(6H)-ones.
The thioether 8c bearing a propargyl substituent was subjected
to  “click”  chemistry  coupling  with  benzyl  azide  or
2-morpholinoethyl azide in the presence of catalytic CuSO4 and
sodium ascorbate to afford the triazoles 9 and 10, respectively,
in  good  yield  (Figure  5).  The  copper-catalyzed  Huisgen
cycloaddition of terminal alkynes and alkyl azides favors form-
ation of the 1,4-triazole regioisomers [22], and in the case of
triazole  9,  this  regiochemistry  was  confirmed  by  1H  NOE
spectra  (see  Supporting  Information  File  2).
Conclusion
In  conclusion,  routes  to  functionalized  oxazolo[5,4-
d]pyrimidines from 2-substituted 5-aminooxazole-4-carboxylic
acid ethyl esters were developed, the key to which is the relat-
ively mild conditions employed in the step-wise elaboration of
the pyrimidine ring. Compounds 2b,c, 7a,b, 8a–d, 9, and 10
were evaluated for their ability to inhibit recombinant, catalytic-
ally active ricin A-chain (RTA) employing a modification of the
previously reported assay [5]. Briefly, the synthesis of protein
from endogenous globin mRNA by rabbit reticulocyte lysate
was determined in the absence of RTA, in the presence of suffi-
cient RTA to inhibit 90% of protein synthesis (ca. 10 pM), and
in the presence of both RTA and increasing concentrations of
the oxazolo[5,4-d]pyrimidines. The ability of these compounds
to  inhibit  RTA  and  thereby  rescue  protein  synthesis  was
determined. Compounds 2b (IC50 = 2.8 mM) and 9 (IC50 = 1.6
mM),  displayed  some  activity;  whereas,  none  of  the  other
compounds examined showed any significant RTA inhibitory
activity.
Supporting Information
Supporting Information File 1
This file includes full experimental details for all new
compounds.
[http://www.beilstein-journals.org/bjoc/content/
supplementary/1860-5397-4-26-S1.doc]
Supporting Information File 2
Copies of 1H and 13C NMR spectra of compounds 2b,c;
3a–c; 5b,c; 6a–c; A; 7a,b; 8a–d; 9; and 10.
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Acknowledgments
Support from DOD/USAMRC DAMD17-03-C-0088 to JDR is
gratefully acknowledged.
Beilstein Journal of Organic Chemistry 2008, 4, No. 26.
Page 5 of
(page number not for citation purposes)
5
References
1. Martin-Kohler, A.; Widmer, J.; Bold, G.; Meyer, T.; Séquin, U.; Traxler,
P. Helv. Chim. Acta 2004, 87, 956–975. doi:10.1002/hlca.200490089
2. Bauser, M.; Delapierre, G.; Hauswald, M.; Flessner, T.; D'Urso, D.;
Hermann, A.; Beyreuther, B.; De Vry, J.; Spreyer, P.; Reissmüller, E.;
Meier, H. Bioorg. Med. Chem. Lett. 2004, 14, 1997–2000. doi:10.1016/
j.bmcl.2004.01.082
3. Holschbach, M. H.; Bier, D.; Stüsgen, S.; Wutz, W.; Sihver, W.;
Coenen, H. H.; Olsson, R. A. Eur. J. Med. Chem. 2006, 41, 7–15.
doi:10.1016/j.ejmech.2005.07.018
4. Claiborne, C. F.; Critchley, S.; Langston, S. P.; Olhava, E. J.; Peluso,
S.; Weatherhead, G. S.; Vyskocil, S.; Visiers, I.; Mizutani, H.; Cullis, C.
Heteroaryl compounds useful as inhibitors of E1 activating enzymes.
PCT Int. Appl. WO 2008/019124 A1, February 14, 2008.
Chem. Abstr. 2008, 148, 262855.
5. Miller, D. J.; Ravikumar, K.; Shen, H.; Suh, J.-K.; Kerwin, S. M.;
Robertus, J. D. J. Med. Chem. 2002, 45, 90–98. doi:10.1021/
jm010186s
6. Falco, E. A.; Elion, G. B.; Burgi, E.; Hitchings, G. H. J. Am. Chem. Soc.
1952, 74, 4897–4902. doi:10.1021/ja01139a049
7. Nishiwaki, T. Nature 1966, 211, 737–738. doi:10.1038/211737a0
8. Temple, C., Jr.; Smith, B. H.; Montgomery, J. A. J. Org. Chem. 1975,
40, 3141–3142. doi:10.1021/jo00909a030
9. Chern, J.-W.; Wise, D. S.; Townsend, L. B. J. Heterocycl. Chem. 1984,
21, 1245–1246.
10. Hurst, D. T.; Atcha, S.; Marshall, K. L. Aust. J. Chem. 1991, 44,
129–134.
11. Jansen, A. B. A.; Szelke, M. J. Chem. Soc. 1961, 405–411.
doi:10.1039/JR9610000405
12. Sekiya, M.; Suzuki, J.; Kakiya, Y. Chem. Pharm. Bull. 1970, 18,
1233–1238.
13. Ohtsuka, Y. Bull. Chem. Soc. Jpn. 1973, 46, 506–509. doi:10.1246/
bcsj.46.506
14. Turchi, I. J.; Maryanoff, C. A. Synthesis 1983, 837–839. doi:10.1055/s-
1983-30535
15. Cabon, G.; Gaucher, B.; Gegout, A.; Heulle, S.; Masquelin, T. Chimia
2003, 57, 248–254. doi:10.2533/000942903777679280
16. Dang, V. T.; Stadlbauer, W. J. Heterocycl. Chem. 1996, 33,
1025–1030.
17. Dounchis, H. J. Org. Chem. 1972, 37, 2583–2587. doi:10.1021/
jo00981a014
18. Kolb, H. C.; Finn, M. G.; Sharpless, K. B. Angew. Chem., Int. Ed. 2001,
40, 2004–2021. doi:10.1002/1521-3773(20010601)40:11<2004::AID-
ANIE2004>3.0.CO;2-5
19. Taylor, E. C.; Cain, C. K. J. Am. Chem. Soc. 1949, 71, 2282–2284.
doi:10.1021/ja01175a002
20. Grifantini, M.; Stein, M. L. Ann. Chim. (Rome, Italy) 1965, 55, 576–582.
Chem. Abstr. 1965, 63, 13234.
21. Griffith, B. R.; Krepel, C.; Fu, X.; Blanchard, S.; Ahmed, A.; Edmiston,
C. E.; Thorson, J. S. J. Am. Chem. Soc. 2007, 129, 8150–8155.
doi:10.1021/ja068602r
22. Rostovtsev, V. V.; Green, L. G.; Fokin, V. V.; Sharpless, K. B. Angew.
Chem., Int. Ed. 2002, 41, 2596–2599. doi:10.1002/1521-
3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4
License and Terms
This is an Open Access article under the terms of the
Creative Commons Attribution License
(http://creativecommons.org/licenses/by/2.0), which
permits unrestricted use, distribution, and reproduction in
any medium, provided  the original work is properly cited.
The license is subject to the Beilstein Journal of Organic
Chemistry terms and conditions:
(http://www.beilstein-journals.org/bjoc)
The definitive version of this article is the electronic one
which can be found at:
doi:10.3762/bjoc.4.26
